These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15446598)

  • 1. [Levels of serum ascorbate and its metabolites in hemodialysis patients].
    Hirano H; Tone Y; Otani H; Oya M; Kimura K; Saika Y; Fujii R; Mune M; Ichinose M; Yukawa S
    Nihon Jinzo Gakkai Shi; 2004 Jul; 46(5):426-33. PubMed ID: 15446598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
    Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
    Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbic acid status in uremics.
    Singh RG; Gupta AK; Dubey SS; Usha ; Sharma MR
    Indian J Med Res; 1992 Aug; 96():266-9. PubMed ID: 1428068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C.
    Eiselt J; Racek J; Opatrný K; Trefil L; Stehlík P
    Blood Purif; 2006; 24(5-6):531-7. PubMed ID: 17077626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
    Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis.
    Hultqvist M; Hegbrant J; Nilsson-Thorell C; Lindholm T; Nilsson P; Lindén T; Hultqvist-Bengtsson U
    Clin Nephrol; 1997 Jan; 47(1):37-46. PubMed ID: 9021240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population.
    Singer R; Rhodes HC; Chin G; Kulkarni H; Ferrari P
    Nephrology (Carlton); 2008 Feb; 13(1):17-22. PubMed ID: 18199096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.
    Shi XF; Ding F; Zhu QY; Xue J; Lu FM; Gu Y; Lin ST
    Ren Fail; 2005; 27(2):213-9. PubMed ID: 15807188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients.
    Pernice F; Floccari F; Nostro L; Caccamo C; Belghity N; Mantuano S; Romeo A; Barilla' A; Aloisi C; Ruello A; Frisina N; Buemi M
    J Nephrol; 2006; 19(5):613-20. PubMed ID: 17136690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients.
    Valentini J; Grotto D; Paniz C; Roehrs M; Burg G; Garcia SC
    Biomed Pharmacother; 2008; 62(6):378-82. PubMed ID: 18166291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma ascorbic acid concentrations in prevalent patients with end-stage renal disease on hemodialysis.
    Sirover WD; Liu Y; Logan A; Hunter K; Benz RL; Prasad D; Avila J; Venkatchalam T; Weisberg LS; Handelman GJ
    J Ren Nutr; 2015 May; 25(3):292-300. PubMed ID: 25455040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The excretion of ascorbic acid and its metabolites in uremia and hemodialysis].
    Bakaev VV; Efremov AV
    Patol Fiziol Eksp Ter; 2000; (2):22-4. PubMed ID: 10846906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of glucose transporter 1 on erythrocyte membrane in hemodialysis patients: the possible role in erythrocyte ascorbate recycling.
    Wann JG; Lin CS; Chang LC; Hsu YH; Chien CT; Tai DW; Chen JS; Yang CC; Yeung LK; Chen CF
    Am J Kidney Dis; 2006 Jun; 47(6):1055-63. PubMed ID: 16731301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human erythrocyte delta-aminolevulinate dehydratase activity and oxidative stress in hemodialysis patients.
    Valentini J; Schmitt GC; Grotto D; Santa Maria LD; Boeira SP; Piva SJ; Brucker N; Bohrer D; Pomblum VJ; Emanuelli T; Garcia SC
    Clin Biochem; 2007 Jun; 40(9-10):591-4. PubMed ID: 17462617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoperoxidation and hemodialysis.
    Ramos R; Martínez-Castelao A
    Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients.
    Fumeron C; Nguyen-Khoa T; Saltiel C; Kebede M; Buisson C; Drüeke TB; Lacour B; Massy ZA
    Nephrol Dial Transplant; 2005 Sep; 20(9):1874-9. PubMed ID: 15972322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
    Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
    J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.